ATE212853T1 - Synergistische orale zusammensetzungen, die eine kombination von lachs-dna mit hydroxyprolin enthalten - Google Patents

Synergistische orale zusammensetzungen, die eine kombination von lachs-dna mit hydroxyprolin enthalten

Info

Publication number
ATE212853T1
ATE212853T1 AT98954551T AT98954551T ATE212853T1 AT E212853 T1 ATE212853 T1 AT E212853T1 AT 98954551 T AT98954551 T AT 98954551T AT 98954551 T AT98954551 T AT 98954551T AT E212853 T1 ATE212853 T1 AT E212853T1
Authority
AT
Austria
Prior art keywords
hydroxyproline
combination
compositions containing
oral compositions
salmon dna
Prior art date
Application number
AT98954551T
Other languages
English (en)
Inventor
Henri Cousse
Jean-Jacques Potherat
Max Rouanet
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Application granted granted Critical
Publication of ATE212853T1 publication Critical patent/ATE212853T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/60Fish, e.g. seahorses; Fish eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT98954551T 1997-11-10 1998-11-10 Synergistische orale zusammensetzungen, die eine kombination von lachs-dna mit hydroxyprolin enthalten ATE212853T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714093A FR2770777B1 (fr) 1997-11-10 1997-11-10 Composition synergique associant de l'acs et/ou de l'adn a de l'hydroxyproline ainsi que leurs applications en nutritherapie et en cosmetologie
PCT/FR1998/002398 WO1999024046A1 (fr) 1997-11-10 1998-11-10 Composition orale synergique associant de l'acs et/ou de l'adn a de l'hydroxyproline

Publications (1)

Publication Number Publication Date
ATE212853T1 true ATE212853T1 (de) 2002-02-15

Family

ID=9513209

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98954551T ATE212853T1 (de) 1997-11-10 1998-11-10 Synergistische orale zusammensetzungen, die eine kombination von lachs-dna mit hydroxyprolin enthalten

Country Status (5)

Country Link
EP (1) EP1030677B1 (de)
AT (1) ATE212853T1 (de)
DE (1) DE69803798T2 (de)
FR (1) FR2770777B1 (de)
WO (1) WO1999024046A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1083929B1 (de) * 1998-06-05 2007-02-14 Nutramax Laboratories, Inc. Verwendung von anabolika, anti-katabolischen mitteln, antioxidanzien und analgetika zum schutz, zur behandlung und reparation von bindegeweben in menschen und tieren
FR2804602B1 (fr) * 2000-02-09 2004-11-19 Serobiologiques Lab Sa Preparations cosmetiques
US6497889B2 (en) * 2000-06-20 2002-12-24 Kyowa Hakko Kogyo Co., Ltd. Cosmetics
JP2002080321A (ja) * 2000-06-20 2002-03-19 Kyowa Hakko Kogyo Co Ltd 化粧料
DE60126829T2 (de) 2001-01-05 2007-12-06 Kyowa Hakko Kogyo Co., Ltd. Kombination von drei Substanzen zur Vorbeugung und Behandlung von Arthritis
CN101404998A (zh) 2006-03-23 2009-04-08 协和发酵工业株式会社 组织胶原合成促进用口服剂
JP5632162B2 (ja) 2007-06-01 2014-11-26 協和発酵バイオ株式会社 経口組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473551A (en) * 1982-08-23 1984-09-25 Faxon Pharmaceuticals, Inc. Anti-inflammatory composition
FR2632186B1 (fr) * 1988-06-03 1992-03-13 Fabre Pierre Cosmetique Compositions dermatocosmetologiques pour le traitement de la senescence cutanee et la prevention des rides
JPH0551400A (ja) * 1991-08-21 1993-03-02 Kanegafuchi Chem Ind Co Ltd 短鎖コラーゲン
US5364845C1 (en) * 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
IT1270095B (it) * 1994-09-28 1997-04-28 Ibsa Inst Biochimique Sa Composizioni terapeutiche di condroitin solfato sotto forma di gel somministrabile per via orale

Also Published As

Publication number Publication date
EP1030677A1 (de) 2000-08-30
DE69803798T2 (de) 2002-10-24
DE69803798D1 (de) 2002-03-21
WO1999024046A1 (fr) 1999-05-20
FR2770777B1 (fr) 2000-02-25
FR2770777A1 (fr) 1999-05-14
EP1030677B1 (de) 2002-02-06

Similar Documents

Publication Publication Date Title
DE3789544T3 (de) Verdickende Zusammensetzungen und verdickte, saure, wässrige Lösungen.
DK288385D0 (da) Aminosyrederivater
DE3686525T2 (de) Hochfeste einkristall-superlegierungszusammensetzungen.
IT8748544A0 (it) Alfa-amminoacidi sostituiti,loro preparazione e composizioni farmaceutiche che li contengono
RU94041224A (ru) Пептиды с органозащитной активностью, фармацевтическая композиция на их основе и их применение в терапии
DE69803798D1 (de) Synergistische orale zusammensetzungen, die eine kombination von lachs-dna mit hydroxyprolin enthalten
WO2002062304A3 (de) Kosmetische und/oder pharmazeutische mittel acylierte aminosäure und proteinkondensat enthaltend.
EA200000884A1 (ru) Производные стрептограминов, их получение и содержащие их композиции
DE3673786D1 (de) Herstellung von indol-alpha-ketosaeure aus alpha-aminosaeure, insbesondere indolpyruvicsaeure.
AR013411A1 (es) Composicion de aplicacion para tratamientos antivirales y afecciones micosicas y/o bacterianas y utilizacion de dichas composiciones.
FI864795A (fi) Komposition innehaollande primicin.
DE3884867T2 (de) Schmiermittel- und Brennstoffzusammensetzungen, die im wesentlichen geradkettige Alkylphenylpolyoxypropylenaminocarbamate enthalten.
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
RU97111095A (ru) Препарат для профилактики и лечения гельминтозов животных "альбамелин"
DE59407572D1 (de) Synergistische Mischungen zur Bekämpfung von Ackerfuchsschwanz
NO943373L (no) Psyliumholdig sammensatt blandingsdrikk
AR008764A1 (es) Sales hidratadas de n,n'-diacetilcistina, proceso para su preparacion, y composiciones terapeuticas que comprenden a dichas sales como ingredienteactivo.
SE8500822D0 (sv) Diazepinoindoles, their production and pharmaceutical compositions containing them
ITRM930686A0 (it) Impiego di altrenogest per la preparazione di composizioni veterinarieiniettabili.
ATE248805T1 (de) Nicht-hygroskopische salze des l-karnitines und der alkanoyl-karnitine enthaltende feste zusammensetzungen zur oralen verabreichung
RU96107872A (ru) Крем для кожи лица "talita"
MY111601A (en) 14-substituted marcfortines and derivatives useful as antiparasitic agents
RU2001128736A (ru) Способ нормализации воспроизводительной функции коров
RU98119825A (ru) Клеевая композиция
RU93056155A (ru) Производные хинолон- и нафтиридон-карбоновой кислоты в виде смеси изомеров или отдельных изомеров, их гидраты и соли

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification